Chien-Ting Liu

机构：National Defense Medical Center · ORCID：0009-0003-6209-2537

发表论文 90 篇 · 总被引 3213 次 · h-index 22

代表论文

• Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial (2020 · The Lancet · 被引 1845)
• Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis (2020 · Journal of Pharmacological Sciences · 被引 105)
• Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer (2024 · Journal of Clinical Oncology · 被引 86)
• The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis (2021 · Complementary Therapies in Medicine · 被引 50)
• Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer (2023 · JAMA Oncology · 被引 28)
• Astragalus polysaccharides improve adjuvant chemotherapy-induced fatigue for patients with early breast cancer (2024 · Scientific Reports · 被引 20)